Assessment of the role and effectiveness of nurse-led multimodal intervention in the rehabilitation of dysphagia in patients with brain tumors.

Support Care CancerSep 10, 2026 (epub)
Clinical ResearchNeurologyOncology (Medical)Physical Medicine & RehabilitationOpen access

Yaping Lu, Haifeng Wu

✦ AI-curated · Sources linked

In 30 seconds

This randomized controlled trial evaluated the effectiveness of a nurse-led multimodal intervention for dysphagia rehabilitation in 120 brain tumor patients. The intervention group, which received personalized swallowing training and nutritional support, showed significant improvements in swallowing function and quality of life compared to the control group, with P < 0.05 for all measured outcomes.

Key findings

  • The intervention group had significantly better Kubota drinking test scores compared to the control group.
  • Saito's swallowing function grading improved more in the intervention group than in the control group.
  • Quality of life scores significantly enhanced in the intervention group compared to the control group.

Why it matters

Dysphagia in brain tumor patients can severely affect health and quality of life. Effective rehabilitation strategies, such as nurse-led interventions, can significantly improve patient outcomes and should be considered in clinical practice.

Source

PubMed · PMID 42720801Free full text on PubMed Central

Published in Support Care Cancer. This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Neurology

Clinical ResearchHematology

Ponatinib-Blinatumomab or Imatinib-Chemotherapy for Adult Ph-Positive ALL.

This multicenter, phase 3 randomized trial compared frontline ponatinib plus blinatumomab with imatinib plus chemotherapy in adults with Philadelphia-positive acute lymphoblastic leukemia.

N Engl J MedOct 15, 2026Read summary
Clinical ResearchHematology

Efficacy and safety of mitapivat in patients with sickle cell disease (RISE UP): a phase 3, double-blind, global, randomised, placebo-controlled trial.

RISE UP was a phase 3, double-blind, global, randomised, placebo-controlled trial conducted at 69 sites in 15 countries. It evaluated twice-daily mitapivat in patients older than 16 years with sickle cell disease…

LancetOct 24, 2026Read summary
Clinical ResearchRheumatology

Ianalumab for the Treatment of Patients with Sjögren's Disease.

Two 52-week, double-blind, randomized, placebo-controlled phase III trials evaluated monthly or less frequent ianalumab in patients with active Sjögren's disease.

N Engl J MedOct 22, 2026Read summary

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text
Create my personalized digestSee plans

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.